Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kohei Kaku

Showing results (1-10 of 370) with videos related to

Pageof 37
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2015
[The trend of new drug development for the treatment of diabetes mellitus]Kohei Kaku
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2002
[Insulin detemir (NN304)]Kohei Kaku
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 11, 2007
[Progress in chemotherapy of type 2 diabetes mellitus]Kohei Kaku
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 29, 2009
[Progress in therapy for diabetes mellitus--insulin-resistance ameliorating agents]Kohei Kaku
Expert Opinion on Pharmacotherapy|May 7, 2014
Efficacy of voglibose in type 2 diabetesKohei Kaku
Expert Opinion on Pharmacotherapy|November 8, 2013
Fasiglifam as a new potential treatment option for patients with type 2 diabetesKohei Kaku
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2002
[Soluble long-acting human insulin analog--action profile and clinical application]Kohei Kaku
Journal of Diabetes Investigation|September 1, 2019
New concept of the glucagon-like peptide-1 signaling pathway on pancreatic insulin secretionKohei Kaku
Expert Opinion on Drug Safety|August 23, 2017
Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patientsKohei Kaku
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 16, 2016
[111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 8. Progress in treatment of diabetes]Kohei Kaku
Pageof 37

Showing results (1-10 of 370) with videos related to

Sort By:
Pageof 37
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 16, 2015
[The trend of new drug development for the treatment of diabetes mellitus]Kohei Kaku
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2002
[Insulin detemir (NN304)]Kohei Kaku
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|April 11, 2007
[Progress in chemotherapy of type 2 diabetes mellitus]Kohei Kaku
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|May 29, 2009
[Progress in therapy for diabetes mellitus--insulin-resistance ameliorating agents]Kohei Kaku
Expert Opinion on Pharmacotherapy|May 7, 2014
Efficacy of voglibose in type 2 diabetesKohei Kaku
Expert Opinion on Pharmacotherapy|November 8, 2013
Fasiglifam as a new potential treatment option for patients with type 2 diabetesKohei Kaku
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 22, 2002
[Soluble long-acting human insulin analog--action profile and clinical application]Kohei Kaku
Journal of Diabetes Investigation|September 1, 2019
New concept of the glucagon-like peptide-1 signaling pathway on pancreatic insulin secretionKohei Kaku
Expert Opinion on Drug Safety|August 23, 2017
Safety evaluation of trelagliptin in the treatment of Japanese type 2 diabetes mellitus patientsKohei Kaku
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 16, 2016
[111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 8. Progress in treatment of diabetes]Kohei Kaku
Pageof 37